---
title: "PHARMACYX LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/74fbbc94-cb86-5fb0-b7cd-49500e2958d9
json: https://whiteintel.dev/api/public/dossier/74fbbc94-cb86-5fb0-b7cd-49500e2958d9
identifier: oo:GB-COH-12645182
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# PHARMACYX LTD

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-12645182`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/74fbbc94-cb86-5fb0-b7cd-49500e2958d9  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/74fbbc94-cb86-5fb0-b7cd-49500e2958d9  

## Ownership & control

### Owners / controllers

- **Mr Matthew Kenneth John Bridges** (beneficial owner) — 50% — https://whiteintel.dev/entity/29010200-d419-5ea3-87d0-b98e16ba8937
- **Benjamin Drew Mayberry** (beneficial owner) — 50% — https://whiteintel.dev/entity/4d4c94e5-15f0-535e-9a40-ab3ca6007d61
- **Mr Paul Robert Mayberry** (beneficial owner) — 50% — https://whiteintel.dev/entity/24af3f7b-bab8-5df6-a6e9-98fcb5c0bf32
- **Mr Matthew Kenneth John Bridges** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/4c466fc4-952f-4987-89d9-a14e059e7f80
- **Mr Paul Robert Mayberry** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/609e285f-5e6d-4f7d-b503-dc8ba8d742c1
- **Benjamin Drew Mayberry** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/45633a2c-e172-4850-9916-dc6dd4acac64

### UBO chain (walk to the ultimate owner)

A **6-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `12645182`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2020-06-04
- **Registered office:** 175 High Street, Blackwood, NP12 0AA, United Kingdom
- **SIC:** 71129

### Officers

- BRIDGES, Matthew Kenneth John — director · British · appointed 2021-04-28
- MAYBERRY, Benjamin Drew — director · British · appointed 2020-06-04

### Beneficial owners (Persons with Significant Control)

- Mr Paul Robert Mayberry — 25–50% shares · individual PSC · Wales — since 2023-04-01
- Mr Matthew Kenneth John Bridges — 25–50% shares · individual PSC · United Kingdom — since 2020-06-06
- Benjamin Drew Mayberry — 25–50% shares · individual PSC · United Kingdom — since 2020-06-04

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/12645182
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/12645182

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **PHARMACYX LTD**. Human view: https://whiteintel.dev/entity/74fbbc94-cb86-5fb0-b7cd-49500e2958d9 · Structured JSON: https://whiteintel.dev/api/public/dossier/74fbbc94-cb86-5fb0-b7cd-49500e2958d9._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._